MedTrace Logo

The Effects of DHA on Periodontitis

NCT01976806 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2017-12-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether docosahexaenoic acid (DHA) is effective in the treatment of periodontitis in adults.

Conditions

Interventions

DRUG

Aspirin

DRUG

Docosahexaenoic acid

DRUG

Placebo (for Docosahexaenoic acid)

Placebo (corn/soybean oil) capsules manufactured to look identical to DHA capsules

Sponsors & Collaborators

Principal Investigators

  • Asghar Z Naqvi, MD, MPH, MNS · Beth Israel Deaconess Medical Center; Harvard Medical School

  • Kenneth J Mukamal, MD, MPH, MA · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976806 on ClinicalTrials.gov